Are you ready to get “red pilled”?!
Perhaps the better question is,
What’s in a “red pill”?
We don’t know much, but we do know this:
- Three active ingredients totaling >100mg.
- All three are chemically related.
- None of the three are ‘PEA back-boned’.
The three come from a group of compounds, about 100, that Bruce Kneller is trying to cover in a non-published patent application currently before the US Patent and Trademark Office (USPTO).
If you’re not familiar with our YouTube channel and aren’t sure what’s going on here, then watch the video below:
Bruce Kneller’s Mystery Stimulant in Action
What’s up with this Bruce-class stimulant?!
Every compound, including the three in the red pill, have been vetted by an industry attorney who is a bona fide subject matter expert in this area. The attorney has provided Bruce with an eight-page Memorandum supporting why these compounds are DSHEA-compliant and why Bruce should be able to legally manufacture and sell any or all of the 100 or so compounds in the United States without any issue whatsoever.
All of these compounds, including the three in the red pill, have been vetted by “a qualified academic (credentialed) scientist” who looked at the structure of these compounds and believes that they are likely to be “biologically active” – this scientist has provided Bruce with a five-page summation of his opinion and findings.
Currently, Bruce is prosecuting his patent application before the USPTO and is waiting for a NOA (notice of allowance) to arise from the application.
Once his findings are “patented”, Bruce intends to have a “by invite only” meeting with the Top 10-20 companies in the industry to allow them proper briefing on these compounds and to provide them with working samples to bring back home to test out and play with.
Dosage ceilings to be enforced
Because safety is paramount to Bruce, there will be “dosing ceilings” per serving written into any company seeking a license of any of these stims. No exceptions!
At this time, Bruce believes that there will never be more than 6-12 companies in total to be allowed to license any of these compounds in order to keep the integrity and value of these compounds both “high” and “cutting edge.”
It all depends on the patent office. Bruce says to expect to see these hit the market by Q4 of 2018 or Q1 of 2019.
Mike and CJ’s written review
First off, CJ liked it better than DMAA. Behind the camera that day, he was laser-focused.
On the other hand, Mike liked it a lot, but a bit less than DMAA… yet more than DMHA or ephedrine (which really only gives him a body buzz).
In general, it was an insanely fun day. Moods were good, everyone was sharp, and everyone was as active as you can be while sitting there talking. You’ll see more videos on our YouTube channel from the day over time – CJ was busy as a bee back there, while Mike and Bruce got into some very interesting topics, starting with Bruce’s big announcement.
No anxiety, no blood pressure, no heat – just good, clean, focused conversations.
This was not noticeably thermogenic, and it provided a fantastic mood and energy feel that made us believe it’d be an incredible workout stimulant and nootropic ingredient first and foremost. Didn’t really feel any noticeable appetite suppression, but we weren’t thinking about that either.
Long story short? The 2018 stimulant race has just added a heavyweight horse!
So now what?
We wait. And given that we’re waiting on the government, it may be some time.
Since this isn’t under a brand and there’s no “PricePlow brand alerts” to sign up for, your best bet is to subscribe to our newsletter via our Deal Alerts:
CJ is ready. Are you?